LONGEVITY SCIENCES HOLDINGS, L.P.
Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.
Raised
$10M
Investors
19
Min Invest
None stated
Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.
What this filing shows
·Every sentence is a value as filed on SEC Form D
LONGEVITY SCIENCES HOLDINGS, L.P. is a Delaware limited partnership that filed a Form D with the SEC on March 31, 2023 in the Other industry group. The offering claims Rule 506(b) and covers equity. LONGEVITY SCIENCES HOLDINGS, L.P. reported $10,000,000 sold from 19 investors of a $10,000,000 total offering as of the Form D filed March 31, 2023. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated. The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. The issuer's address of record is 228 Park Avenue S., Pmb 28994, New York, NY 10003.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govFilings on Record
Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.
In the Terminal
Filing events
0
none on file
Critical / warning
0 / 0
0 watch · 0 info
Statements extracted
0
none on file
NAV prints
0
none on file
Offering chains
1
closed
Investor
- 1 offering timeline: velocity, share raised, first-sale lag, stalled flags
Pro
- This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
- The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV
Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…
Related Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
LCG4 MANAGERS, L.L.C.
Executive Officer, Director · NEW YORK, NY
THE ISSUER'S GENERAL PARTNER
MELANIE GOLDEY
Executive Officer, Director · NEW YORK, NY
CHIEF EXECUTIVE OFFICER
WHITNEY CASEY
Director · NEW YORK, NY
MATT NUGENT
Director · NEW YORK, NY
DAVID SINCLAIR
Director · NEW YORK, NY
KIRSTEN GREEN
Director · NEW YORK, NY
Questions About LONGEVITY SCIENCES HOLDINGS, L.P.
Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.
What is LONGEVITY SCIENCES HOLDINGS, L.P.?
LONGEVITY SCIENCES HOLDINGS, L.P. is a Delaware limited partnership that filed a Form D with the SEC on March 31, 2023 in the Other industry group. The filing claims Rule 506(b) for an offering of equity.
Is LONGEVITY SCIENCES HOLDINGS, L.P. legit?
AltStreet does not rate legitimacy; it reports the public record. LONGEVITY SCIENCES HOLDINGS, L.P. filed a Form D with the SEC on March 31, 2023 claiming Rule 506(b). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $10,000,000 sold to 19 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.
Is LONGEVITY SCIENCES HOLDINGS, L.P. registered with or approved by the SEC?
No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that LONGEVITY SCIENCES HOLDINGS, L.P. claimed Rule 506(b) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.
How much has LONGEVITY SCIENCES HOLDINGS, L.P. raised?
LONGEVITY SCIENCES HOLDINGS, L.P. reported $10,000,000 sold from 19 investors of a $10,000,000 total offering as of the Form D filed March 31, 2023.
Who can invest in LONGEVITY SCIENCES HOLDINGS, L.P.?
The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated.
What is the minimum investment in LONGEVITY SCIENCES HOLDINGS, L.P.?
The Form D lists the minimum investment as $0, which means the issuer did not state a minimum on the form. The offering documents, not the Form D, set the actual subscription terms.
Who is selling LONGEVITY SCIENCES HOLDINGS, L.P. and how are they paid?
The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly.
Who is behind LONGEVITY SCIENCES HOLDINGS, L.P.?
The Form D lists 6 related persons: LCG4 MANAGERS, L.L.C., executive officer, director (THE ISSUER'S GENERAL PARTNER); MELANIE GOLDEY, executive officer, director (CHIEF EXECUTIVE OFFICER); WHITNEY CASEY, director; MATT NUGENT, director; DAVID SINCLAIR, director; KIRSTEN GREEN, director. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.
Where is LONGEVITY SCIENCES HOLDINGS, L.P. located?
The issuer's address on its SEC filings is 228 Park Avenue S., Pmb 28994, New York, NY 10003. Its phone number of record is 917-477-9226. It is organized under the laws of Delaware.
How long is the LONGEVITY SCIENCES HOLDINGS, L.P. offering open?
The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open, and no amendment is on record yet.
What is LONGEVITY SCIENCES HOLDINGS, L.P.'s revenue?
The issuer declined to disclose its revenue range on the Form D, which the form permits.
Is this your company or fund?
Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.
Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.